Growth Inhibition of CD20‐positive B Lymphoma Cell Lines by IDEC‐C2B8 Anti‐CD20 Monoclonal Antibody
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
1972 • 15,349 citations
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
1994 • 2,450 citations
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
1994 • 1,969 citations
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
1994 • 1,932 citations
Shrinkage necrosis: A distinct mode of cellular death
1971 • 1,448 citations
A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
1989 • 1,436 citations
Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18
1985 • 1,188 citations
Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
1997 • 1,082 citations
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma
1994 • 747 citations
REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
1988 • 703 citations
CD20: a regulator of cell-cycle progression of B lymphocytes
1994 • 583 citations
Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies
1998 • 576 citations
Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors
1992 • 551 citations
Tumor-Specific Idiotype Vaccines in the Treatment of Patients With B-Cell Lymphoma — Long-Term Results of a Clinical Trial
1997 • 464 citations
Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro
1995 • 435 citations
A clinical trial of anti-idiotype therapy for B cell malignancy
1985 • 434 citations
Monoclonal Antibodies in Diagnosis and Therapy
1991 • 378 citations
Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype
1989 • 356 citations
Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
1984 • 246 citations
The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
1985 • 232 citations
Monoclonal antibody-based therapies of leukemia and lymphoma
1992 • 213 citations
The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle.
1985 • 178 citations
Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes
1986 • 146 citations
Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40
1992 • 142 citations
Quantitative analysis of leukocyte membrane antigen expression: Normal adult values
1996 • 124 citations
Terminal deoxynucleotidyl transferase activity in a cell line (Molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia
1973 • 87 citations
Quantitative determination of surface antibody binding capacities of immune subsets present in peripheral blood of healthy adult donors
1996 • 41 citations
Engagement of CD20 suppresses apoptosis in germinal center B cells
1995 • 39 citations
Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation
1986 • 38 citations
Human leukemic “null” cell line (NALL-1)
1977 • 31 citations
Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations.
1991 • 21 citations
Establishment of a new human B cell line carrying t(11;14) chromosome abnormality.
1987 • 13 citations
Pharmacokinetic analysis of serum concentrations of the chimeric anti-CD20 antibody IDEC-C2B8 in patients with relapsed B cell lymphoma
1995 • 3 citations